SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-18-102246
Filing Date
2018-03-29
Accepted
2018-03-29 17:25:18
Documents
4
Effectiveness Date
2018-03-29

Document Format Files

Seq Description Document Type Size
1 S-8 d525346ds8.htm S-8 49340
2 EX-5.1 d525346dex51.htm EX-5.1 6315
3 EX-23.1 d525346dex231.htm EX-23.1 1657
4 GRAPHIC g525346g0328134737991.jpg GRAPHIC 2505
  Complete submission text file 0001193125-18-102246.txt   61926
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-224033 | Film No.: 18724052
SIC: 2834 Pharmaceutical Preparations